Citadel Advisors »

Iovance Biotherapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.2M 1.0M 8.13
2023-09-30 $5.8M 1.3M 4.55
2023-06-30 $13M 1.8M 7.04
2023-03-31 $24M 3.9M 6.11
2022-12-31 $17M 2.6M 6.39
2022-06-30 $32M 2.9M 11.04
2022-03-31 $13M 773k 16.65
2021-12-31 $13M 659k 19.09
2021-09-30 $44M 1.8M 24.66
2021-06-30 $72M 2.8M 26.02
2021-03-31 $34M 1.1M 31.66
2020-12-31 $78M 1.7M 46.40
2020-09-30 $47M 1.4M 32.92
2020-06-30 $58M 2.1M 27.45
2020-03-31 $16M 549k 29.94
2019-12-31 $15M 547k 27.75
2019-09-30 $9.3M 513k 18.13
2019-06-30 $14M 589k 24.52
2019-03-31 $18M 1.9M 9.51
2018-12-31 $40M 4.5M 8.85
2018-09-30 $38M 3.4M 11.34
2018-06-30 $6.4M 503k 12.81
2018-03-31 $4.0M 235k 16.92
2017-12-31 $346k 43k 8.03
2017-09-30 $513k 66k 7.75